Perphenazine: Clinical Trials

22 trials of Perphenazine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 3 unknown, 2 terminated, 1 withdrawn. 7 Phase 4, 5 Phase 3, 3 Not applicable, 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 47Completed 6, Withdrawn 1
Phase 35Completed 3, Terminated 1, Unknown 1
Not applicable3Completed 3
Phase 12Completed 2
Phase 22Unknown 2

Follow Perphenazine: new trials by email Literature Review of Perphenazine trials Research Report on Perphenazine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data
Neuraxial Analgesia, Regional Block 1: Paravertebral, Perphenazine - Perioperative Optimization
Phase 3CompletedJennifer Holder-Murray33952023-05-152026-05-28
Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE
Riociguat, Propylthiouracil, Perphenazine - Ischemic Stroke, Acute
Phase 2UnknownMaastricht University282022-09-052023-10-19
Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers
Propylthiouracil, Riociguat, Perphenazine - Drug Drug Interaction, Safety Issues
Phase 1CompletedMaastricht University82021-03-182022-04-04
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Lithium Carbonate, Lamotrigine, Valproic Acid - Bipolar Disorder
TerminatedUniversity of New Mexico10373522016-09-012024-03-12
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
Caregiver psycho-education and skills training, Caregiver support available at the study site, Paliperidone palmitate - Schizophrenia
CompletedJanssen Scientific Affairs, LLC2962015-07-242019-01-23
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
Aripiprazole, Haloperidol, Olanzapine - Schizophrenia, Psychotic Disorders
Phase 3CompletedJanssen Scientific Affairs, LLC3372015-07-082025-04-29
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
Olanzapine, Amisulpride, Risperidone - Schizophrenia, Schizophrenia and Disorders With Psychotic Features
Phase 4CompletedTechnical University of Munich212015-02-012018-10-11
Pharmacovigilance in Gerontopsychiatric Patients
Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression
Phase 3TerminatedHannover Medical School4072015-01-012018-02-28
Lurasidone Effects on Tissue Glutamate in Schizophrenia
Lurasidone, Haloperidol, Perphenazine - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedUniversity of Texas Southwestern Medical Center352013-02-012021-03-01
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
Discontinuation antipsychotic treatment, Antipsychotic treatment - Psychosis Nos/Other
Phase 3UnknownFundación Pública Andaluza Progreso y Salud1042012-11-012014-12-05
A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
Typical antipsychotic, Risperidone, Olanzapine - Schizophrenia
Not applicableCompletedBeijing HuiLongGuan Hospital5502012-06-012016-07-12
Antipsychotics and Risk of Hyperglycemic Emergencies
Olanzapine, Risperidone, atypical antipsychotics (other) - Psychotic Disorders, Schizophrenia
CompletedCanadian Network for Observational Drug Effect Studies, CNODES7254892012-04-012015-10-21
Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction
reduction of risperidone, haloperidol, olanzapine, quetiapine, aripiprazole, paliperidone, levomepromazine, perphenazine - Schizophrenia Relapse
Not applicableCompletedJuntendo University1392011-04-012021-09-09
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
paliperidone palmitate, risperidone, olanzapine - Schizophrenia
Phase 4WithdrawnOrtho-McNeil Janssen Scientific Affairs, LLC2010-08-012013-07-08
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
paliperidone, risperidone, haloperidole - Schizophrenia
Phase 4CompletedJanssen Scientific Affairs, LLC4502010-05-012015-04-24
Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
Aripiprazole or Perphenazine, Metformin, Olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole, asenapine, iloperidone, lurasidone, paliperidone, or olanzapine/fluoxetine - Psychotic Disorders
Phase 4CompletedJohns Hopkins University1272009-01-012017-04-25
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
Olanzapine, Perphenazine, Aripiprazole - Schizophrenia
Phase 4CompletedNational Institute of Mental Health (NIMH)212008-12-012013-02-08
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
Aripiprazole, Perphenazine - Schizophrenia, Cocaine Dependence
Phase 2UnknownPaul Saenger442008-08-012012-09-07
A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer
BL 1020, Perphenazine - Healthy
Phase 1CompletedBioLineRx, Ltd.2007-05-012009-07-21
Antipsychotic Polypharmacy in Schizophrenia
2 antipsychotic medications (combinations of olanzapine, risperidone, clozapine, seroquel, haldol, perphenazine), main antipsychotic medication and placebo - Schizophrenia
Not applicableCompletedCentre for Addiction and Mental Health1002006-11-012009-05-19

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Schizophrenia (13)  ·  Psychotic Disorders (6)  ·  Bipolar Disorder (2)  ·  Dementia (2)  ·  Alzheimer Disease (1)  ·  Anxiety Disorders (1)  ·  Cocaine-Related Disorders (1)  ·  Dementia, Vascular (1)  ·  Depression (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Ischemic Stroke (1)  ·  Obesity (1)  ·  Postoperative Nausea and Vomiting (1)

Sponsors

Janssen Scientific Affairs, LLC (3)  ·  Maastricht University (2)  ·  National Institute of Mental Health (NIMH) (2)  ·  Beijing HuiLongGuan Hospital (1)  ·  BioLineRx, Ltd. (1)  ·  Bruce Pollock (1)  ·  Canadian Network for Observational Drug Effect Studies, CNODES (1)  ·  Centre for Addiction and Mental Health (1)  ·  Fundación Pública Andaluza Progreso y Salud (1)  ·  Hannover Medical School (1)  ·  Jennifer Holder-Murray (1)  ·  Johns Hopkins University (1)  ·  Juntendo University (1)  ·  Ortho-McNeil Janssen Scientific Affairs, LLC (1)  ·  Paul Saenger (1)

Countries

United States (11)  ·  Germany (4)  ·  Canada (2)  ·  Brazil (1)  ·  China (1)  ·  Mexico (1)  ·  Puerto Rico (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Bruce G. Pollock, M.D., Ph.D. (1)  ·  Carol A Tamminga, M.D. (1)  ·  Christoph Correll, MD (1)  ·  Christophe G Lambert, PhD (1)  ·  David Mamo, MD, MSc (1)  ·  Gloria Reeves, MD (1)  ·  Helge Frieling, Prof., MD (1)  ·  Jeffrey A Lieberman, MD (1)  ·  Joseph P. McEvoy, MD (1)  ·  Linmarie Sikich, MD (1)  ·  Lorraine Lipscombe, MD, MSc (1)  ·  Mark A. Riddle, MD (1)  ·  Markus Dold, MD (1)

Results publications

PMID 37756123, PMID 16172203, PMID 16585434, PMID 16585435, PMID 17151158, PMID 17151159, PMID 19640511, PMID 20816031, PMID 20868641, PMID 22000938, PMID 22290266, PMID 22316567, PMID 23235268, PMID 23727135, PMID 24028745, PMID 24030617, PMID 24183751, PMID 24400912, PMID 24524169, PMID 24569099, PMID 24581419, PMID 24581550, PMID 24630140, PMID 24726579, PMID 24850369, PMID 24862257, PMID 25075930, PMID 25375367, PMID 25562591, PMID 25567425, PMID 25668654, PMID 25679125, PMID 25938474, PMID 26403322, PMID 26479222, PMID 26581028, PMID 26742509, PMID 26845273, PMID 27180047, PMID 28441618, PMID 28693755, PMID 28901625, PMID 29069114, PMID 29920885, PMID 30172739, PMID 30986735, PMID 31237566, PMID 31651956, PMID 31744781, PMID 32220153

NIH funding

N01MH090001 (2), N01MH90001 (2), 2019 (1), R01MH059666 (1), R01MH080270 (1)